Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Stock Symbol
-
INAB on Nasdaq
There are no Buy or Sell transactions made by Leslie W. Kreis since 10/13/2024
Holdings reported by Leslie W. Kreis for In8 Bio, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
3.73M |
$559K |
$0.15 |
May 2, 2025 |
By Bios Fund III QP, LP |
|
|
| Common Stock |
1.88M |
$281K |
$0.15 |
May 2, 2025 |
By Bios Fund II QP, LP |
|
|
| Common Stock |
997K |
$150K |
$0.15 |
May 2, 2025 |
By BIOS Incysus Co-Invest I, LP |
|
|
| Common Stock |
602K |
$90.3K |
$0.15 |
May 2, 2025 |
By Bios Fund III, NT, LP |
|
|
| Common Stock |
574K |
$86.2K |
$0.15 |
May 2, 2025 |
By Bios Fund II, LP |
|
|
| Common Stock |
571K |
$85.6K |
$0.15 |
May 2, 2025 |
By Bios Fund III, LP |
|
|
| Common Stock |
251K |
$37.7K |
$0.15 |
May 2, 2025 |
By Bios Fund II NT, LP |
|
|
| Pre-Funded Warrants |
2.43M |
|
|
May 2, 2025 |
By Bios Clinical Opportunity Fund, LP |
Common Stock |
|
| Series C Warrant |
709K |
|
|
May 2, 2025 |
By Bios Clinical Opportunity Fund, LP |
Common Stock |
|
| Stock Option |
85K |
|
|
May 2, 2025 |
Indirect |
Common Stock |
85K |
| Series A Warrant |
0 |
|
|
May 2, 2025 |
By Bios Clinical Opportunity Fund, LP |
Common Stock |
|
| Series B Warrant |
0 |
|
|
May 2, 2025 |
By Bios Clinical Opportunity Fund, LP |
Common Stock |
574K |
Transactions reported by Leslie W. Kreis for In8 Bio, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.